A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled and Deucravacitinib Active Comparator-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

  • Lai, Francis (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description



StatusActive
Effective start/end date20/05/24 → 19/05/29